Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

盘前交易 05-02 08:09:48 EDT

98.91

+2.91

+3.03%

最高102.95	最低95.39	成交量66.45万
今开96.28	昨收96.00	日振幅7.88%
总市值49.61亿	流通市值47.89亿	总股本5,016万
成交额6,629万	换手率1.37%	流通股本4,841万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":98.91,"timestamp":1714593600000,"preClose":96,"halted":0,"volume":664475,"delay":0,"floatShares":48412917,"shares":50160369,"eps":-2.780356,"marketStatus":"盘前交易","marketStatusCode":1,"change":2.91,"latestTime":"05-02 08:09:48 EDT","open":96.28,"high":102.95,"low":95.39,"amount":66286182.081875004,"amplitude":0.07875,"askPrice":106.56,"askSize":20,"bidPrice":60.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.780356,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714656600000},"adr":0,"listingDate":1435204800000,"adjPreClose":98.91,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":97,"preClose":98.91,"latestTime":"18:58 EDT","volume":9664,"amount":955669.24,"timestamp":1714604330342},"volumeRatio":1.51989571432481},"requestUrl":"/m/hq/s/GKOS/tweets","defaultTab":"tweets","newsList":[{"id":"2432062756","title":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由108.00美元调整至113.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432062756","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432062756?lang=zh_cn&edition=full","pubTime":"2024-05-02 17:55","pubTimestamp":1714643753,"startTime":"0","endTime":"0","summary":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由108.00美元调整至113.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021755558b6cad74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405021755558b6cad74&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431821604","title":"Glaukos Corp   预计每股亏损57美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431821604","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431821604?lang=zh_cn&edition=full","pubTime":"2024-04-30 05:35","pubTimestamp":1714426513,"startTime":"0","endTime":"0","summary":"   * Glaukos Corp    将于5月1日公布截至2024年3月31日的业绩报告，预计季度收入将有所增长。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于加利福尼亚州艾利索维埃霍的公司的营收将从去年同期的7390万美元增长7.7%，达到7960万美元。* LSEG分析师对Glaukos公司的平均预期是每股亏损57美分。* 华尔街对 Glaukos Corp 的 12 个月目标价中值为 107.00 美元，高于其 97.20 美元的最新收盘价。4月29日 - 以前的季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431189863","title":"Glaukos Corporation涨0.72% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2431189863","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431189863?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:33","pubTimestamp":1714397590,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时33分，Glaukos Corporation股票出现波动，股价大幅拉升0.72%。截至发稿，该股报100.20美元/股，成交量3486股，换手率0.01%，振幅0.63%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.58%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292133108b624f18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292133108b624f18&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430828649","title":"Glaukos Corporation跌2.24% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2430828649","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430828649?lang=zh_cn&edition=full","pubTime":"2024-04-25 21:34","pubTimestamp":1714052043,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日21时34分，Glaukos Corporation股票出现异动，股价快速跳水2.24%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.19%。其相关个股中，Nuwellis, Inc.、Autonomix Medical, Inc.、Reshape Lifesciences, Inc.涨幅较大，Nuwellis, Inc.、Sintx Technologies, Inc.、Heart Test Laboratories, Inc.较为活跃，换手率分别为47.32%、2.09%、1.23%，振幅较大的相关个股有Lensar, Inc.、艾利科技、Nuwellis, Inc.，振幅分别为6.13%、5.75%、5.08%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521340387af69ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042521340387af69ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426254073","title":"瑞穗银行：维持Glaukos(GKOS.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2426254073","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426254073?lang=zh_cn&edition=full","pubTime":"2024-04-11 20:49","pubTimestamp":1712839763,"startTime":"0","endTime":"0","summary":"瑞穗银行：维持Glaukos(GKOS.US)评级，由中性调整至中性评级,目标价由85.00美元调整至100.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112057128b106886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112057128b106886&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426971901","title":"Glaukos Corporation跌0.69% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2426971901","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426971901?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:49","pubTimestamp":1712670583,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时49分，Glaukos Corporation股票出现异动，股价大幅下挫0.69%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.33%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。消息层面，截至21时49分，《Truist Securities：重申Glaukos评级，由买入调整至买入评级, 目标价由110.00美元调整至110.00美元。》资讯为影响Glaukos Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214944861e43b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409214944861e43b9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425914037","title":"Truist Securities：重申Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由110.00美元调整至110.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2425914037","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425914037?lang=zh_cn&edition=full","pubTime":"2024-04-08 23:25","pubTimestamp":1712589933,"startTime":"0","endTime":"0","summary":"Truist Securities：重申Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由110.00美元调整至110.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082325408754faff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082325408754faff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425911141","title":"Glaukos Corporation涨3.34% 股价突破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2425911141","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425911141?lang=zh_cn&edition=full","pubTime":"2024-04-08 23:07","pubTimestamp":1712588862,"startTime":"0","endTime":"0","summary":"北京时间2024年04月08日23时07分，Glaukos Corporation股票出现异动，股价快速上涨3.34%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.20%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。消息层面，截至23时07分，《Form 144 | Glaukos高管拟出售2,457股股份，价值约23.79万美元》资讯为影响Glaukos Corporation的重要信息。此外，Gilliam Joseph E自2024年1月12日起至今合共已减持该公司18.59万股股份，总价值约1,715.17万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082307427a51694b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404082307427a51694b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424841953","title":"Glaukos Corporation盘中异动 急速上涨5.20%报94.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424841953","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424841953?lang=zh_cn&edition=full","pubTime":"2024-04-03 21:51","pubTimestamp":1712152314,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日21时51分，Glaukos Corporation股票出现波动，股价快速拉升5.20%。截至发稿，该股报94.13美元/股，成交量5.4335万股，换手率0.11%，振幅3.63%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.63%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403215155791ebfb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403215155791ebfb2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424007901","title":"Glaukos Corporation盘中异动 股价大跌5.01%报88.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424007901","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424007901?lang=zh_cn&edition=full","pubTime":"2024-04-03 02:44","pubTimestamp":1712083442,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日02时44分，Glaukos Corporation股票出现波动，股价快速下挫5.01%。截至发稿，该股报88.44美元/股，成交量40.2747万股，换手率0.81%，振幅4.01%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为1.38%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403024402861e3113&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240403024402861e3113&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417422834","title":"Glaukos Corporation盘中异动 临近收盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417422834","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417422834?lang=zh_cn&edition=full","pubTime":"2024-03-06 04:36","pubTimestamp":1709670985,"startTime":"0","endTime":"0","summary":"北京时间2024年03月06日04时36分，Glaukos Corporation股票出现波动，股价快速下挫5.02%。截至发稿，该股报84.11美元/股，成交量41.677万股，换手率0.84%，振幅4.46%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为1.35%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604362587e7627b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030604362587e7627b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414701249","title":"Glaukos Corporation2023财年实现净利润-1.35亿美元，同比减少36.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414701249","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414701249?lang=zh_cn&edition=full","pubTime":"2024-02-25 00:22","pubTimestamp":1708791748,"startTime":"0","endTime":"0","summary":"12月31日，Glaukos Corporation公布财报，公告显示公司2023财年净利润为-1.35亿美元，同比减少36.09%；其中营业收入为3.15亿美元，同比增加11.31%，每股基本收益为-2.78美元。从资产负债表来看，Glaukos Corporation总负债4.79亿美元，其中短期债务--，资产负债比为1.97，流动比率为0.06。机构评级：截至2023年12月31日，当前有12家机构对Glaukos Corporation目标价做出预测，其中目标均价为103.08美元，其中最低目标价为84.00美元，最高目标价为115.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500223887babd40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500223887babd40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412190240","title":"Glaukos Corp   预计每股亏损55美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412190240","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412190240?lang=zh_cn&edition=full","pubTime":"2024-02-20 11:01","pubTimestamp":1708398114,"startTime":"0","endTime":"0","summary":"   * Glaukos Corp    将于2月21日公布截至2023年12月31日的财报，预计季度收入将有所增长。* 根据LSEG的数据，13位分析师的平均预期显示，这家总部位于加利福尼亚州圣克莱门特的公司的营收将从去年同期的7123万美元增至7868.8万美元，增幅为10.5%。* LSEG分析师对Glaukos公司的平均预期是每股亏损55美分。* 华尔街对 Glaukos Corp 的 12 个月目标价中值为 101.00 美元，高于其上一次收盘价 92.63 美元。2月20日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2402513171","title":"Glaukos Corporation盘中异动 早盘股价大涨5.24%报86.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402513171","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402513171?lang=zh_cn&edition=full","pubTime":"2024-01-09 22:55","pubTimestamp":1704812123,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日22时55分，Glaukos Corporation股票出现异动，股价大幅拉升5.24%。截至发稿，该股报86.30美元/股，成交量7.3791万股，换手率0.15%，振幅5.98%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.75%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922552379076a6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010922552379076a6f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402964097","title":"Glaukos Corporation盘中异动 股价大涨5.16%报83.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402964097","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402964097?lang=zh_cn&edition=full","pubTime":"2024-01-09 01:12","pubTimestamp":1704733967,"startTime":"0","endTime":"0","summary":"北京时间2024年01月09日01时12分，Glaukos Corporation股票出现波动，股价快速拉升5.16%。截至发稿，该股报83.20美元/股，成交量23.7778万股，换手率0.49%，振幅3.72%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.67%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010901124779071b0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024010901124779071b0d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393412503","title":"Glaukos Corporation盘中异动 下午盘股价大跌5.37%报80.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393412503","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393412503?lang=zh_cn&edition=full","pubTime":"2023-12-23 02:59","pubTimestamp":1703271571,"startTime":"0","endTime":"0","summary":"北京时间2023年12月23日02时59分，Glaukos Corporation股票出现波动，股价大幅下跌5.37%。截至发稿，该股报80.54美元/股，成交量39.4215万股，换手率0.81%，振幅6.32%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.09%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312230259327a35596a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312230259327a35596a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2393483936","title":"Glaukos Corporation盘中异动 大幅拉升5.01%报83.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2393483936","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2393483936?lang=zh_cn&edition=full","pubTime":"2023-12-21 23:54","pubTimestamp":1703174088,"startTime":"0","endTime":"0","summary":"北京时间2023年12月21日23时54分，Glaukos Corporation股票出现异动，股价急速上涨5.01%。截至发稿，该股报83.59美元/股，成交量19.682万股，换手率0.40%，振幅3.47%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.60%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122123544887e61045&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023122123544887e61045&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391697295","title":"Glaukos Corporation盘中异动 早盘大幅拉升5.09%报79.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2391697295","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391697295?lang=zh_cn&edition=full","pubTime":"2023-12-16 00:20","pubTimestamp":1702657234,"startTime":"0","endTime":"0","summary":"北京时间2023年12月16日00时20分，Glaukos Corporation股票出现异动，股价快速上涨5.09%。截至发稿，该股报79.60美元/股，成交量65.0157万股，换手率1.33%，振幅6.40%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为1.04%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121600203484767a17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121600203484767a17&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391032635","title":"Glaukos Corporation盘中异动 股价大涨10.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391032635","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391032635?lang=zh_cn&edition=full","pubTime":"2023-12-14 22:33","pubTimestamp":1702564390,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日22时33分，Glaukos Corporation股票出现异动，股价急速上涨10.10%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.27%。其相关个股中，Spectral Ai Inc C/Wts 09/11/2028 、Thermogenesis Holdings Inc、Pacific Biosciences California Inc涨幅较大，Reshape Lifesciences Inc、Glaukos Corporation、Heart Test Laboratories Inc较为活跃，换手率分别为37.58%、0.99%、0.95%，振幅较大的相关个股有Spectral Ai Inc C/Wts 09/11/2028 、Nexalin Technology Inc、Reshape Lifesciences Inc，振幅分别为23.09%、11.47%、10.35%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121422331183f90f24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121422331183f90f24&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":-0.02},{"period":"1month","weight":0.0624},{"period":"3month","weight":0.0766},{"period":"6month","weight":0.5404},{"period":"1year","weight":1.1767},{"period":"ytd","weight":0.2443}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation，于1998年7月14日在美国特拉华州注册成立，是一个治疗青光眼的开发商，制造商和医疗设备商。该公司是一家眼科医疗技术公司，专注于设计、开发、改造和商业化治疗青光眼的突破性产品和程序，青光眼也是世界上引起失明的主要原因之一。该公司已率先微创青光眼手术，或MIGS，彻底改变了传统青光眼的治疗和管理模式。","yearOnYearQuotes":[{"month":1,"riseRate":0.888889,"avgChangeRate":0.091165},{"month":2,"riseRate":0.666667,"avgChangeRate":0.018112},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.005207},{"month":4,"riseRate":0.555556,"avgChangeRate":0.016877},{"month":5,"riseRate":0.555556,"avgChangeRate":0.011342},{"month":6,"riseRate":0.875,"avgChangeRate":0.120169},{"month":7,"riseRate":0.777778,"avgChangeRate":0.042158},{"month":8,"riseRate":0.333333,"avgChangeRate":0.031864},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.019442},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.029449},{"month":11,"riseRate":0.444444,"avgChangeRate":0.004688},{"month":12,"riseRate":0.444444,"avgChangeRate":0.004734}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}